Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EDAP EDAP TMS	$1.36 +7.9%	$1.56	$1.21 ▼ $4.42	$47.11M	-0.09	63,324 shs	78,452 shs
OSRH OSR	$0.56 -4.7%	$1.17	$0.56 ▼ $13.40	$11.37M	1.49	1.30 million shs	177,602 shs
WOK WORK Medical Technology Group	$0.78 -1.4%	$0.78	$0.36 ▼ $8.45	$44.72M	N/A	54,122 shs	9,248 shs
ZYXI Zynex	$1.58 +11.3%	$2.23	$1.23 ▼ $9.42	$43.02M	0.91	523,650 shs	216,285 shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EDAP EDAP TMS	+1.20%	-0.79%	-17.38%	-42.20%	-71.36%
OSRH OSR	-2.37%	-9.98%	-50.03%	-51.27%	+58,959,900.00%
WOK WORK Medical Technology Group	-0.05%	+3.50%	+6.28%	+42.45%	+79,499,900.00%
ZYXI Zynex	-2.07%	-17.68%	-36.61%	-34.56%	-81.29%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EDAP EDAP TMS	2.9181 of 5 stars	3.2	5.0	0.0	0.0	2.2	1.7	0.6
OSRH OSR	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WOK WORK Medical Technology Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ZYXI Zynex	3.0633 of 5 stars	3.2	2.0	0.0	0.0	3.3	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EDAP EDAP TMS	2.33	Hold	$8.50	525.00% Upside
OSRH OSR	0.00	N/A	N/A	N/A
WOK WORK Medical Technology Group	0.00	N/A	N/A	N/A
ZYXI Zynex	2.33	Hold	$4.90	210.13% Upside

Current Analyst Ratings Breakdown

Latest OSRH, EDAP, WOK, and ZYXI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/1/2025	ZYXI Zynex	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$3.70
8/1/2025	ZYXI Zynex	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
7/15/2025	ZYXI Zynex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$4.00 ➝ $3.00
6/30/2025	ZYXI Zynex	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$8.00
5/15/2025	EDAP EDAP TMS	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral

(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EDAP EDAP TMS	$69.18M	0.74	N/A	N/A	$1.18 per share	1.15
OSRH OSR	N/A	N/A	N/A	N/A	($3.87) per share	N/A
WOK WORK Medical Technology Group	$11.51M	3.83	N/A	N/A	$1.10 per share	0.71
ZYXI Zynex	$192.35M	0.25	$0.27 per share	5.82	$0.04 per share	39.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EDAP EDAP TMS	-$20.58M	-$0.62	N/A	N/A	N/A	-34.45%	-51.42%	-26.43%	8/28/2025 (Estimated)
OSRH OSR	-$2.41M	N/A	0.00	∞	N/A	N/A	-36.89%	-19.14%	N/A
WOK WORK Medical Technology Group	-$3.49M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ZYXI Zynex	$2.99M	-$0.94	N/A	3.36	N/A	-19.79%	-78.54%	-16.70%	10/30/2025 (Estimated)

Latest OSRH, EDAP, WOK, and ZYXI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/28/2025	Q2 2025	EDAP EDAP TMS	-$0.18	N/A	N/A	N/A	$16.60 million	N/A
5/20/2025	Q1 2025	OSRH OSR	N/A	-$1.04	N/A	-$1.04	N/A	$0.76 million
5/15/2025	Q1 2025	EDAP EDAP TMS	-$0.16	-$0.20	-$0.04	-$0.20	$16.56 million	$16.37 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EDAP EDAP TMS	N/A	N/A	N/A	N/A	N/A
OSRH OSR	N/A	N/A	N/A	N/A	N/A
WOK WORK Medical Technology Group	N/A	N/A	N/A	N/A	N/A
ZYXI Zynex	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EDAP EDAP TMS	0.10	1.74	1.21
OSRH OSR	N/A	0.25	0.20
WOK WORK Medical Technology Group	N/A	N/A	N/A
ZYXI Zynex	0.56	0.62	0.45

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EDAP EDAP TMS	62.74%
OSRH OSR	55.30%
WOK WORK Medical Technology Group	N/A
ZYXI Zynex	29.68%

Insider Ownership

Company	Insider Ownership
EDAP EDAP TMS	0.23%
OSRH OSR	33.67%
WOK WORK Medical Technology Group	N/A
ZYXI Zynex	49.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EDAP EDAP TMS	230	37.39 million	37.31 million	Optionable
OSRH OSR	N/A	19.28 million	12.79 million	N/A
WOK WORK Medical Technology Group	226	56.53 million	N/A	N/A
ZYXI Zynex	770	30.30 million	15.37 million	Optionable

OSRH, EDAP, WOK, and ZYXI Headlines

Recent News About These Companies

Zynex Q2 Revenue Drops 55%

August 5, 2025 | fool.com

Zynex Inc. Faces Challenges Amid Strategic Shifts

August 4, 2025 | theglobeandmail.com

Zynex (NASDAQ:ZYXI) Upgraded at LADENBURG THALM/SH SH

August 4, 2025 | americanbankingnews.com

Zynex (NASDAQ:ZYXI) Downgraded to Neutral Rating by HC Wainwright

August 4, 2025 | americanbankingnews.com

Zynex (NASDAQ:ZYXI) Raised to "Buy" at LADENBURG THALM/SH SH

August 2, 2025 | marketbeat.com

Zynex (NASDAQ:ZYXI) Rating Lowered to "Neutral" at HC Wainwright

August 2, 2025 | marketbeat.com

Zynex, Inc. (NASDAQ:ZYXI) Q2 2025 Earnings Call Transcript

August 1, 2025 | msn.com

HC Wainwright & Co. Downgrades Zynex (ZYXI)

August 1, 2025 | msn.com

Zynex, Inc.: Zynex Reports Second Quarter 2025 Financial Results

August 1, 2025 | finanznachrichten.de

Zynex Inc (ZYXI) Q2 2025 Earnings Report Preview: What to Look For

August 1, 2025 | finance.yahoo.com

Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript

July 31, 2025 | seekingalpha.com

Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates

July 31, 2025 | zacks.com

Zynex eyes growth revival under new CEO, advances oximeter technology

July 31, 2025 | proactiveinvestors.com

Zynex Reports Second Quarter 2025 Financial Results

July 31, 2025 | prnewswire.com

Zynex Sets Second Quarter 2025 Earnings Call

July 22, 2025 | prnewswire.com

Zynex (ZYXI) to Release Quarterly Earnings on Wednesday

July 16, 2025 | marketbeat.com

Royal Bank Of Canada Issues Pessimistic Forecast for Zynex (NASDAQ:ZYXI) Stock Price

July 15, 2025 | marketbeat.com

Zynex: New CEO Steven Dyson shares his vision â€“ ICYMI

July 12, 2025 | proactiveinvestors.com

Zynex: New CEO Steven Dyson shares his vision – ICYMI

July 12, 2025 | proactiveinvestors.com

Zynex Shareholder Sues Board, Execs Over Insurer’s Payment Pause

July 11, 2025 | news.bloomberglaw.comN

ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 10, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSRH, EDAP, WOK, and ZYXI Company Descriptions

EDAP TMS NASDAQ:EDAP

$1.36 +0.10 (+7.94%)

As of 04:00 PM Eastern

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

OSR NASDAQ:OSRH

$0.56 -0.03 (-4.68%)

As of 04:00 PM Eastern

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

WORK Medical Technology Group NASDAQ:WOK

$0.78 -0.01 (-1.40%)

Closing price 03:55 PM Eastern

Extended Trading

$0.78 0.00 (0.00%)

As of 04:27 PM Eastern

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Zynex NASDAQ:ZYXI

$1.58 +0.16 (+11.27%)

Closing price 04:00 PM Eastern

Extended Trading

$1.59 +0.01 (+0.63%)

As of 07:56 PM Eastern

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time